Inhibitory Effect of Dimethyl Sulfoxide on the Mutagenicity of Promutagens in the Ames Test
スポンサーリンク
概要
著者
-
Hori Yuji
Department of Blood Transfusion Medicine, Nara Medical University
-
Uchida Kanako
Global Drug Safety Eisai Co. Ltd.
-
Aoki Toyohiko
Global Drug Safety Eisai Co. Ltd.
-
Sawada Shigeki
Global Drug Safety Eisai Co. Ltd.
-
Hori Yuji
Department Of Drug Safety Research Sunplanet Co. Ltd.
-
Hakura Atsushi
Global Drug Safety Eisai Co. Ltd.
-
Tsukidate Kazuo
Global Drug Safety Eisai Co. Ltd.
-
SUGANUMA Akiyoshi
Global Drug Safety, Eisai Co., Ltd.
-
Hori Yuji
Department Of Blood Transfusion Medicine Nara Medical University
-
Suganuma Akiyoshi
Global Drug Safety Eisai Co. Ltd.
関連論文
- Influenza A Infection Triggers Thrombotic Thrombocytopenic Purpura by Producing the Anti-ADAMTS13 IgG Inhibitor
- P-15 Investigational study for hepatotoxicity in rats by E2011 repeated administration. 2) Bioactivation of benzothiazoles with amine structures in the Ames mutagenicity assay.(Proceedings of the 27th Annual Meeting)
- A New Type of Inclusion Compounds Composed of a Charge-Transfer Complex between Tetrakis(phenylethynyl)ethene and 2,4,7-Trinitrofluorenone
- P-11 Application of hepatocytes cultured in a sandwich configuration to toxicity assessment.(Proceedings of the 27th Annual Meeting)
- Mechanism for benzothiazole derivative-induced hepatotoxicity in rats(SYMPOSIUM 1 : MECHANISMS OF HEPATOTOXIC EFFECTS)
- TOXICOLOGICAL RESPONSE OF RATS TO A NOVEL MONOAMINE OXIDASE TYPE-A INHIBITOR, (5R)-3-[2-((1S)-3-CYANO-1-HYDROX-YPROPYL)BENZOTHIAZOL-6-YL]-5-METHOXYMETHYL-2-OXAZOLIDI-NONE (E2011), ORALLY ADMINISTERED FOR 13 WEEKS
- Inhibitory Effect of Dimethyl Sulfoxide on the Mutagenicity of Promutagens in the Ames Test
- Cytotoxic Effect of Dimethyl Sulfoxide in the Ames Test
- Proteolytic fragmentation and sugar chains of plasma ADAMTS13 purified by a conformation-dependent monoclonal antibody
- Study of the Time-resolved IR Spectrum of α-Arylvinyl Cations Generated by Laser Flash Photolysis
- ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease score